• Je něco špatně v tomto záznamu ?

Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience

J. Smetana, J. Frohlich, R. Zaoralova, V. Vallova, H. Greslikova, R. Kupska, P. Nemec, A. Mikulasova, M. Almasi, L. Pour, Z. Adam, V. Sandecka, L. Zahradová, R. Hajek, P. Kuglik,

. 2014 ; 2014 (-) : 209670.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu klinické zkoušky, časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc15014169

Grantová podpora
NT13492 MZ0 CEP - Centrální evidence projektů

Characteristic recurrent copy number aberrations (CNAs) play a key role in multiple myeloma (MM) pathogenesis and have important prognostic significance for MM patients. Array-based comparative genomic hybridization (aCGH) provides a powerful tool for genome-wide classification of CNAs and thus should be implemented into MM routine diagnostics. We demonstrate the possibility of effective utilization of oligonucleotide-based aCGH in 91 MM patients. Chromosomal aberrations associated with effect on the prognosis of MM were initially evaluated by I-FISH and were found in 93.4% (85/91). Incidence of hyperdiploidy was 49.5% (45/91); del(13)(q14) was detected in 57.1% (52/91); gain(1)(q21) occurred in 58.2% (53/91); del(17)(p13) was observed in 15.4% (14/91); and t(4;14)(p16;q32) was found in 18.6% (16/86). Genome-wide screening using Agilent 44K aCGH microarrays revealed copy number alterations in 100% (91/91). Most common deletions were found at 13q (58.9%), 1p (39.6%), and 8p (31.1%), whereas gain of whole 1q was the most often duplicated region (50.6%). Furthermore, frequent homozygous deletions of genes playing important role in myeloma biology such as TRAF3, BIRC1/BIRC2, RB1, or CDKN2C were observed. Taken together, we demonstrated the utilization of aCGH technique in clinical diagnostics as powerful tool for identification of unbalanced genomic abnormalities with prognostic significance for MM patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15014169
003      
CZ-PrNML
005      
20191011102001.0
007      
ta
008      
150420s2014 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1155/2014/209670 $2 doi
035    __
$a (PubMed)24987674
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Smetana, Jan $u Department of Experimental Biology, Faculty of Science, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic ; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic. $7 xx0128923
245    10
$a Genome-wide screening of cytogenetic abnormalities in multiple myeloma patients using array-CGH technique: a Czech multicenter experience / $c J. Smetana, J. Frohlich, R. Zaoralova, V. Vallova, H. Greslikova, R. Kupska, P. Nemec, A. Mikulasova, M. Almasi, L. Pour, Z. Adam, V. Sandecka, L. Zahradová, R. Hajek, P. Kuglik,
520    9_
$a Characteristic recurrent copy number aberrations (CNAs) play a key role in multiple myeloma (MM) pathogenesis and have important prognostic significance for MM patients. Array-based comparative genomic hybridization (aCGH) provides a powerful tool for genome-wide classification of CNAs and thus should be implemented into MM routine diagnostics. We demonstrate the possibility of effective utilization of oligonucleotide-based aCGH in 91 MM patients. Chromosomal aberrations associated with effect on the prognosis of MM were initially evaluated by I-FISH and were found in 93.4% (85/91). Incidence of hyperdiploidy was 49.5% (45/91); del(13)(q14) was detected in 57.1% (52/91); gain(1)(q21) occurred in 58.2% (53/91); del(17)(p13) was observed in 15.4% (14/91); and t(4;14)(p16;q32) was found in 18.6% (16/86). Genome-wide screening using Agilent 44K aCGH microarrays revealed copy number alterations in 100% (91/91). Most common deletions were found at 13q (58.9%), 1p (39.6%), and 8p (31.1%), whereas gain of whole 1q was the most often duplicated region (50.6%). Furthermore, frequent homozygous deletions of genes playing important role in myeloma biology such as TRAF3, BIRC1/BIRC2, RB1, or CDKN2C were observed. Taken together, we demonstrated the utilization of aCGH technique in clinical diagnostics as powerful tool for identification of unbalanced genomic abnormalities with prognostic significance for MM patients.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    12
$a chromozomální aberace $7 D002869
650    _2
$a srovnávací genomová hybridizace $x metody $7 D055028
650    _2
$a ženské pohlaví $7 D005260
650    12
$a celogenomová asociační studie $7 D055106
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mnohočetný myelom $x diagnóza $x genetika $7 D009101
650    _2
$a nádorové proteiny $x genetika $7 D009363
650    _2
$a prognóza $7 D011379
651    _2
$a Česká republika $7 D018153
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Fröhlich, Jan. $u Department of Experimental Biology, Faculty of Science, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic ; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic. $7 xx0240724
700    1_
$a Zaoralová, Romana $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic. $7 xx0126082
700    1_
$a Vallová, Vladimíra, $u Department of Experimental Biology, Faculty of Science, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic. $d 1979- $7 mub2011669456
700    1_
$a Grešliková, Henrieta $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic. $7 xx0122004
700    1_
$a Kupská, Renata $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic. $7 xx0128684
700    1_
$a Němec, Pavel $u Department of Experimental Biology, Faculty of Science, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic ; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic. $7 xx0162732
700    1_
$a Mikulášová, Aneta $u Department of Experimental Biology, Faculty of Science, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic ; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic. $7 _AN050306
700    1_
$a Almasi, Martina $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic ; Department of Internal Hematooncology, University Hospital Brno, Bohunice, 62500 Brno, Czech Republic. $7 gn_A_00004597
700    1_
$a Pour, Luděk $u Department of Clinical Hematology, University Hospital Brno, Bohunice, 62500 Brno, Czech Republic. $7 xx0102556
700    1_
$a Adam, Zdeněk $u Department of Clinical Hematology, University Hospital Brno, Bohunice, 62500 Brno, Czech Republic. $7 jn19981000018
700    1_
$a Sandecká, Viera $u Department of Clinical Hematology, University Hospital Brno, Bohunice, 62500 Brno, Czech Republic. $7 xx0129325
700    1_
$a Szeligová, Lenka $u Faculty of Medicine, University of Ostrava and University Hospital Ostrava, Poruba, 70852 Ostrava, Czech Republic. $7 xx0098951
700    1_
$a Hájek, Roman, $u Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic ; Department of Internal Hematooncology, University Hospital Brno, Bohunice, 62500 Brno, Czech Republic ; Faculty of Medicine, University of Ostrava and University Hospital Ostrava, Poruba, 70852 Ostrava, Czech Republic. $d 1964- $7 nlk20000083645
700    1_
$a Kuglík, Petr, $u Department of Experimental Biology, Faculty of Science, Masaryk University Brno, Bohunice, 62500 Brno, Czech Republic. $d 1957- $7 ola2003204793
773    0_
$w MED00182164 $t BioMed research international $x 2314-6141 $g Roč. 2014, č. - (2014), s. 209670
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24987674 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150420 $b ABA008
991    __
$a 20191011102421 $b ABA008
999    __
$a ok $b bmc $g 1071750 $s 897047
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 2014 $c - $d 209670 $i 2314-6141 $m BioMed research international $n Biomed Res Int $x MED00182164
GRA    __
$a NT13492 $p MZ0
LZP    __
$a Pubmed-20150420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...